A Pro250Arg substitution in mouse Fgfr1 causes increased expression of Cbfa1 and premature fusion of calvarial sutures

Human Molecular Genetics

Volumn 9, Issue 13, 2000, Pages 2001-2008

  Zhou, Y X ^a   Xu, X ^a   Chen, L ^a   Li, C ^a   Brodie, S G ^a   Deng, C X ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ARGININE; FIBROBLAST GROWTH FACTOR RECEPTOR; LIGAND; PROLINE; TRANSCRIPTION FACTOR;

ACROCEPHALOSYNDACTYLY; AMINO ACID SUBSTITUTION; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CRANIAL SUTURE; CRANIOFACIAL SYNOSTOSIS; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSFECTION; IN VITRO STUDY; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0034641606     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/9.13.2001     Document Type: Article

References (64)

1. Craniosynostosis syndromes
2. The FGF family of growth factors and oncogenes
3. Functions of fibroblast growth factors in vertebrate development
4. Structural and functional diversity in the FGF receptor multigene family
5. Fibroblast growth factors as multi-functional signaling factors
6. The roles of FGFs in the early development of vertebrate limbs
7. Two FGF receptor genes are differentially expressed in epithelial and mesenchymal tissues during limb formation and organogenesis in the mouse
8. Developmental expression of two murine fibroblast growth factor receptors, flg and bek
9. Expression of the fibroblast growth factor receptor FGFR-1/flg during gastrulation and segmentation in the mouse embryo
10. Blood-borne macromolecule induces FGF receptor gene expression after focal ischemia
11. Developmental localization of the splicing alternatives of fibroblast growth factor receptor-2 (FGFR2)
12. Unique expression pattern of the FGF receptor 3 gene during mouse organogenesis
13. FGFR-4, a new member of the fibroblast growth factor receptor family, expressed in the definitive endoderm and skeletal muscle lineages of the mouse
14. Murine FGFR-1 is required for early postimplantation growth and axial organization
15. Fibroblast growth factor receptor-1 (FGFR-1) is essential for normal neural tube and limb development
16. Murine fibroblast growth factor receptor 1alpha isoforms mediate node regression and are essential for posterior mesoderm development
17. fgfr-1 is required for embryonic growth and mesodermal patterning during mouse gastrulation
18. Fibroblast growth factor receptor 2 (FGFR2)-mediated reciprocal regulation loop between FGF8 and FGF10 is essential for limb induction
19. Targeted disruption of fibroblast growth factor (FGF) receptor 2 suggests a role for FGF signaling in pregastrulation mammalian development
20. Fibroblast growth factor receptor 3 is a negative regulator of bone growth
21. Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3
22. Fibroblast growth factor receptor-3 and receptor-4 function cooperatively to direct alveogenesis in the murine lung
23. Dominant erbliche Akrocephalosyndaktylie.
24. Pfeiffer syndrome update, clinical subtypes, and guidelines for differential diagnosis
25. A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome
26. Efficient in vivo manipulation of mouse genomic sequences at the zygote stage
27. Sutural biology and the correlates of craniosynostosis
28. A Lys644Glu substitution in fibroblast growth factor receptor 3 (FGFR3) causes dwarfism in mice by activation of STATs and ink4 cell cycle inhibitors
29. A mouse model for achondroplasia produced by targeting fibroblast growth factor receptor 3
30. Gly369Cys mutation in mouse FGFR3 causes achondroplasia by affecting both chondrogenesis and osteogenesis
31. Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia
32. Osteocalcin and matrix Gla protein: Vitamin K-dependent proteins in bone
33. Expression of bone sialoprotein (BSP) in developing human tissues
34. Osteopontin: A protein with diverse functions
35. Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation
36. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts
37. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development
38. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia
39. Cbfa1 is required for epithelial-mesenchymal interactions regulating tooth development in mice
40. Activation of FGF receptors by mutations in the transmembrane domain
41. FGF signaling inhibits chondrocyte proliferation and regulates bone development through the STAT-1 pathway
42. Msx2 gene dosage influences the number of proliferative osteogenic cells in growth centers of the developing murine skull: A possible mechanism for MSX2-mediated craniosynostosis in humans
43. Premature suture closure and ectopic cranial bone in mice expressing Msx2 transgenes in the developing skull
44. A mutation in the homeodomain of the human MSX2 gene in a family affected with autosomal dominant craniosynostosis
45. Dorsoventral patterning in Xenopus: Inhibition of ventral signals by direct binding of chordin to BMP-4
46. FGF-, BMP-and Shh-mediated signaling pathways in the regulation of cranial suture morphogenesis and calvarial bone development
47. Fgfr2 and osteopontin domains in the developing skull vault are mutually exclusive and can be altered by locally applied FGF2
48. Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3
49. Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia
50. A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia
51. Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia
52. FGFR activation in skeletal disorders: Too much of a good thing
53. Activation of Stat1 by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism
54. Repression of hedgehog signaling and BMP4 expression in growth plate cartilage by fibroblast growth factor receptor 3
55. Fgfr1 and Fgfr2 have distinct differentiation- and proliferation-related roles in the developing mouse skull vault
56. Missense mutations abolishing DNA binding of the osteoblast-specific transcription factor OSF2/CBFA1 in cleidocranial dysplasia
57. A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development
58. MAPK pathways activate and phosphorylate the osteoblast-specific transcription factor, cbfa1
59. Location of cross-overs during gene targeting with insertion and replacement vectors
60. The tumor suppressor SMAD4/DPC4 is essential for epiblast proliferation and mesoderm induction in mice
61. Differential staining of cartilage and bone in whole mouse fetuses by alcian blue and alizarin red S
62. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor
63. Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta
64. Cbfa1 isoform over-expression upregulates osteocalcin gene expression in non-osteoblastic and pre-osteoblastic cells